Basit öğe kaydını göster

dc.contributor.authorAlkan, A
dc.contributor.authorErdem, E
dc.contributor.authorGunhan, O
dc.contributor.authorKarasu, C
dc.date.accessioned2020-06-21T15:45:37Z
dc.date.available2020-06-21T15:45:37Z
dc.date.issued2002
dc.identifier.issn0278-2391
dc.identifier.issn1531-5053
dc.identifier.urihttps://doi.org/10.1053/joms.2002.33859
dc.identifier.urihttps://hdl.handle.net/20.500.12712/21999
dc.descriptionWOS: 000177329300012en_US
dc.descriptionPubMed: 12149735en_US
dc.description.abstractPurpose: Bone healing is impaired in diabetes mellitus, particularly due to increased collagen breakdown. Recently, tetracyclines have been used to treat experimental bone defects because they have anticollagenolytic properties, and positive effects on the healing process have been obtained. The objective of this study was to develop a computer-assisted histomorphometric technique to quantitatively determine the amount of regenerating bone within experimental bone defects in a diabetic rodent model. Materials and Methods: This study examined the effects of systemic doxycycline administration on the healing of tibial bone defects in healthy albino rats and in experimentally induced diabetic rats. Twenty-four female albino rats were assigned to 4 groups: diabetic, diabetic plus doxycycline, control, or control plus doxycycline. The standardized bone defects were histomorphometrically examined 10 and 30 days postoperatively. Histomorphometric analysis of the amount of new bone formation was performed using the Zeiss Vision image analysis program KS 400 (Kontron Elektron GmbH, Eching, Germany). Results: At 10 days of healing, the diabetic groups exhibited inferior healing compared with the control groups in terms of the amount of new bone formation within the defects. However, the effect of doxycycline administration to the diabetic and control groups was not statistically different. At 30 days of healing, there were no statistically significant differences between the amount of newly formed bone in any of the groups. Conclusions: This study found that doxycycline administration did not significantly alter the amount of new bone formation during the healing of bone defects in control and diabetic rats. (C) 2002 American Association of Oral and Maxillofacial Surgeons.en_US
dc.language.isoengen_US
dc.publisherW B Saunders Co-Elsevier Incen_US
dc.relation.isversionof10.1053/joms.2002.33859en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleHistomorphometric evaluation of the effect of doxycycline on the healing of bone defects in experimental diabetes mellitus: A pilot studyen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume60en_US
dc.identifier.issue8en_US
dc.identifier.startpage898en_US
dc.identifier.endpage904en_US
dc.relation.journalJournal of Oral and Maxillofacial Surgeryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster